top of page
Building bridges between innovation and commercialization.
Audrey Guazzone is a cross-border commercialization strategist helping healthtech companies grow across borders through market validation, strategic partnerships, and hands-on execution.
As the founder of LeanLia, she works with innovative companies navigating critical growth decisions—from validating new markets to accelerating commercialization and building strategic partnerships internationally.
Her work combines commercial strategy with practical execution, helping companies reduce risk, make informed decisions, and move forward with confidence.
Why I Created LeanLIa
Throughout my career, I've worked at the intersection of healthcare innovation, product management, international business development, and commercialization.
Along the way, I noticed the same challenge repeated itself.
Innovative companies were often making significant investments before validating whether the opportunity truly existed. Others received thoughtful strategic advice but lacked the local presence and commercial support needed to execute successfully.
I created LeanLia to bridge that gap.
Today, LeanLia helps healthtech companies reduce commercial risk, validate market opportunities, develop strategic partnerships, and accelerate commercialization—combining strategic thinking with hands-on execution .
Every engagement is grounded in the same practical principles that have shaped my career from the beginning.
Why LeanLIa?
LEAN reflects the belief that companies grow more successfully when they validate early, invest progressively, and make decisions based on evidence rather than assumptions.
My interest in lean methods began through software product innovation and organizing a Lean Startup Challenge in Boston. Those experiences showed me how structured experimentation and validated learning could dramatically reduce risk and lead to better commercial decisions.
LIA reflects another important part of LeanLia's identity: acting as a trusted liaison between companies, markets, experts, and strategic partners. Whether helping a European healthtech company navigate the U.S. market or connecting organizations across international innovation ecosystems, my role has always been to build bridges that turn opportunities into lasting partnerships.
The name also holds a personal significance, inspired by my family, making LeanLia a business built on both professional purpose and personal commitment.
Together, "Lean" and "Lia" capture what LeanLia stands for: practical, evidence-based growth supported by trusted relationships and cross-border collaboration.
BEYOND CLIENT ENGAGEMENTS
I actively contribute to organizations that strengthen innovation ecosystems and foster international collaboration between entrepreneurs, healthcare leaders, investors, researchers, and public institutions.
Today, I serve on the Board of Directors of Health2Tech, advancing digital health through international events and community building. I also serve on the Board of La French Tech Washington DC, helping strengthen connections between French and American entrepreneurs, investors, and innovation leaders.
Beyond these roles, I collaborate with innovation agencies, clusters, accelerators, universities, and economic development organizations on initiatives that support entrepreneurship, innovation, and cross-border growth. These collaborations occasionally extend beyond healthtech into broader innovation sectors, including AI, climate technologies, smart infrastructure, and regional economic development.
These experiences keep me closely connected to emerging technologies, international innovation ecosystems, and strategic partnerships—bringing broader perspective and valuable relationships to every client engagement.
Whether you're exploring a new market, preparing for commercialization, strengthening international partnerships, or looking to better understand your next commercial opportunity, I'd be happy to learn more about your goals and discuss how LeanLia can help.
bottom of page